Heffter Research Institute
Heffter Research Institute
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, depressive disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Early phase 1 | 2026-09-04 | NCT04123314 | |
| Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 | 2026-07-07 | NCT04161066 | |
| Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 1 | 2025-11-05 | NCT03554174 |